A detailed history of Comerica Bank transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Comerica Bank holds 7,692 shares of FLGT stock, worth $140,994. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,692
Previous 7,648 0.58%
Holding current value
$140,994
Previous $150,000 11.33%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$19.6 - $25.06 $862 - $1,102
44 Added 0.58%
7,692 $167,000
Q2 2024

Aug 15, 2024

SELL
$19.09 - $22.57 $19,376 - $22,908
-1,015 Reduced 11.72%
7,648 $150,000
Q1 2024

May 15, 2024

SELL
$21.55 - $29.29 $28,532 - $38,779
-1,324 Reduced 13.26%
8,663 $187,000
Q4 2023

Feb 14, 2024

SELL
$23.64 - $30.27 $1,489 - $1,907
-63 Reduced 0.63%
9,987 $288,000
Q3 2023

Nov 21, 2023

BUY
$26.74 - $40.81 $268,737 - $410,140
10,050 New
10,050 $268,000
Q4 2022

Jan 26, 2023

SELL
$29.23 - $40.28 $106,835 - $147,223
-3,655 Reduced 23.74%
11,742 $0
Q3 2022

Oct 28, 2022

SELL
$37.92 - $63.74 $51,760 - $87,005
-1,365 Reduced 8.14%
15,397 $584,000
Q2 2022

Aug 02, 2022

BUY
$47.98 - $62.75 $22,310 - $29,178
465 Added 2.85%
16,762 $990,000
Q1 2022

Apr 27, 2022

BUY
$49.85 - $96.11 $26,919 - $51,899
540 Added 3.43%
16,297 $1.02 Million
Q4 2021

Feb 18, 2022

SELL
$77.3 - $105.0 $125,612 - $170,625
-1,625 Reduced 9.35%
15,757 $1.58 Million
Q3 2021

Nov 22, 2021

BUY
$74.87 - $110.87 $58,398 - $86,478
780 Added 4.7%
17,382 $1.56 Million
Q2 2021

Aug 26, 2021

SELL
$66.8 - $100.45 $69,939 - $105,171
-1,047 Reduced 5.93%
16,602 $1.53 Million
Q1 2021

Apr 28, 2021

BUY
$59.3 - $183.85 $227,000 - $703,777
3,828 Added 27.7%
17,649 $1.71 Million
Q4 2020

Jan 28, 2021

BUY
$31.01 - $52.1 $48,623 - $81,692
1,568 Added 12.8%
13,821 $720,000
Q3 2020

Oct 30, 2020

BUY
$15.89 - $50.51 $194,700 - $618,899
12,253 New
12,253 $490,000

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $555M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Comerica Bank Portfolio

Follow Comerica Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.